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Abstract
Introduction The human genome-scale metabolic recon-
struction details all known metabolic reactions occurring in
humans, and thereby holds substantial promise for studying
complex diseases and phenotypes. Capturing the whole
human metabolic reconstruction is an on-going task and
since the last community effort generated a consensus
reconstruction, several updates have been developed.
Objectives We report a new consensus version, Recon 2.2,
which integrates various alternative versions with signifi-
cant additional updates. In addition to re-establishing a
consensus reconstruction, further key objectives included
providing more comprehensive annotation of metabolites
and genes, ensuring full mass and charge balance in all
reactions, and developing a model that correctly predicts
ATP production on a range of carbon sources.
Methods Recon 2.2 has been developed through a combi-
nation of manual curation and automated error checking.
Specific and significant manual updates include a respeci-
fication of fatty acid metabolism, oxidative phosphorylation
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and a coupling of the electron transport chain to ATP syn-
thase activity. All metabolites have definitive chemical
formulae and charges specified, and these are used to ensure
full mass and charge reaction balancing through an auto-
mated linear programming approach. Additionally,
improved integration with transcriptomics and proteomics
data has been facilitated with the updated curation of rela-
tionships between genes, proteins and reactions.
Results Recon 2.2 now represents the most predictive
model of human metabolism to date as demonstrated here.
Extensive manual curation has increased the reconstruction
size to 5324 metabolites, 7785 reactions and 1675 associ-
ated genes, which now are mapped to a single standard.
The focus upon mass and charge balancing of all reactions,
along with better representation of energy generation, has
produced a flux model that correctly predicts ATP yield on
different carbon sources.
Conclusion Through these updates we have achieved the
most complete and best annotated consensus human
metabolic reconstruction available, thereby increasing the
ability of this resource to provide novel insights into nor-
mal and disease states in human. The model is freely
available from the Biomodels database (http://identifiers.
org/biomodels.db/MODEL1603150001).
Keywords Human  Metabolism  Modelling 
Reconstruction  Model  Systems biology
1 Introduction
Metabolic processes are implicated in many important
aspects of human health. Models are critical in the explo-
ration and understanding of the complexity underlying
human metabolism. Genome-scale models of human
metabolism [Recon 1 (Duarte et al. 2007) and Recon 2
(Thiele et al. 2013)] have been used to predict biomarkers
of inborn errors of metabolism (Shlomi et al. 2009), to
identify drug targets (Frezza et al. 2011) and off-target
drug effects (Thiele et al. 2013), to study cancer metabo-
lism (Lewis and Abdel-Haleem 2013) and to improve
understanding of microbial interactions with the host
organism (Bordbar et al. 2010; Heinken and Thiele 2015).
Furthermore, while human metabolic reconstructions are of
obvious utility in the medical and pharmacological fields, it
is worth noting that reconstructions of mammalian bio-
chemical networks also act as blueprints for modelling
systems of biotechnological significance, such as Chinese
Hamster Ovary (CHO; Kaas et al. 2014) and Human
Embryonic Kidney (HEK; Quek et al. 2014) cells. As these
networks improve, their applications across basic, clinical
and biotechnological research will continue to expand.
The core of a predictive metabolic model is a reconstruc-
tion of the underlying reaction network, which catalogues all
metabolic reactions encoded within the genome. (One can
consider a reconstruction to be a comprehensive knowledge
base of biochemistry, covering metabolic reactions and their
enzymes, and a metabolic model to be a mathematical rep-
resentation of the reconstruction.) Naturally, the reconstruc-
tion should be both accurate and complete. The most recent
human metabolic reconstruction, Recon 2, was published
following a large international community effort to develop a
consensus reconstruction from existing resources. This
reconstruction was of a considerably larger scale than its
predecessors and therefore represented an important
advancement. Since its publication, Recon 2 has served as a
valuable resource for many studies. As is common for such
reconstructions, new knowledge about cell metabolism is
regularly discovered and these insights must be added to the
reconstruction. Furthermore, the use of reconstructions in
modelling studies identifies necessary corrections. Thus, for
Recon 2, updates and refinements could strengthen the accu-
racy of its predictions (Swainston et al. 2013;Quek et al. 2014;
Kell and Goodacre 2014).
Following the release of Recon 2, several updates were
published (Quek et al. 2014; Sahoo et al. 2014, 2015).
These updates provided better definition of transport pro-
teins, a wider consideration of drug metabolism, and a
number of error corrections. An additional update, Recon
2.1 (Smallbone 2013) focused upon improving carbon
balancing but did not cover full stoichiometric mass and
charge balancing of every reaction. As such, there is a need
for identifying imbalances to ensure accurate predictions of
energy metabolism.
In this update, a number of errors are corrected and
various improvements introduced to capture human meta-
bolism more accurately and completely. Extensive manual
curation has increased the reconstruction size, which now
contains 5324 compartmentalised metabolites (of which
2652 are unique chemical species), 7785 reactions, and
1675 associated genes (Table 1). The focus upon mass and
charge balancing of all reactions, along with better repre-
sentation of energy generation, has produced a model that
correctly predicts ATP flux on different carbon sources.
Thus, through these updates, we have achieved the most
complete and best-annotated consensus human metabolic
reconstruction available. We demonstrate that Recon 2.2 is,
to our knowledge, the first mammalian metabolic model to
predict (free) energy production correctly, based upon
carbon availability.
The model is freely available from the Biomodels
database (Chelliah et al. 2015), under the identifier
MODEL1603150001 (http://identifiers.org/biomodels.db/
MODEL1603150001).
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2 Materials and methods
Recon 2.2 is an extension of Recon 2.1 (Smallbone,
2013). A series of manual curation steps led to the
development of an interim version, Recon 2.1.5. Fol-
lowing this, a semi-automated curation approach was
implemented, in which model updates were specified in
simple, human-readable text files. These text files were
interpreted by an updated version of the SuBliMinaL
Toolbox (Swainston et al. 2011), built on libChEBI
(Swainston et al. 2016), in order to automate the pro-
duction of Recon 2.2 from Recon 2.1.5. All models, text
files and software used to build Recon 2.2 are freely
available from https://github.com/mcisb/mcisb-recon
along with instructions on their use.
Semi-automatic mapping of NCBI identifiers resolved
HGNC identifiers but also revealed duplicates, pseudoge-
nes, ESTs and other non-gene records, which have been
removed. The resulting reconstruction contains 1675 genes.
All gene associations are expressed using disjunctive nor-
mal form: (A and B) or (A and C) rather than A and (B or
C). This consistency facilitates the writing of parsers, but
more importantly is the correct representation of the
underlying biology, explicitly specifying genes in terms of
the complexes their products form.
Beta-oxidation of fatty acids in the mitochondria and
peroxisome was expanded to account explicitly for inter-
mediary fatty acyl-CoA moieties and the full suite of
enzymes necessary for complete oxidation of fatty acids.
By breaking down lumped beta-oxidation reactions into the
component two-carbon cycles, the differing specificities of
the enzymes catalysing the first dehydrogenase/oxidase
step can be resolved. We additionally clarified the gene-
protein-reaction (GPR) relationships for these reactions to
include the enzymes required for the full beta-oxidation
cycle (acyl-CoA dehydrogenase/oxidase, enoyl CoA
hydratase, 3-hydroxyacyl-CoA dehydrogenase, and b-ke-
tothiolase) as well as enzymes utilized for unsaturated fatty
acid beta-oxidation (dienoyl-CoA reductase and/or enoyl-
CoA isomerase).
The modelling utility of these improvements is
demonstrated via a suite of tests. The test suite was
developed in Python 2.7, and is available at https://github.
com/mcisb/mcisb-recon-analysis. The test suite checks
reaction balancing, ATP production under a range of
nutrient sources, and the size of the reconstruction and its
constituent elements. It can be run against any model that
adheres to the COBRA convention (Schellenberger et al.
2011) of SBML formatting, and—similar to the concept of
unit testing in software development (Yoo and Harman
2012)—can therefore be used to validate incremental
updates to Recon 2.2 as the model develops further.
3 Results and discussion
The original goal of Recon 2 was to create a consensus
from existing reconstructions. Recently published updates
resulted in different versions of Recon 2, and these have all
been incorporated into Recon 2.2 to create a new consen-
sus. These include updates to transporter reactions (Sahoo
et al. 2014), drug effects and metabolism (Sahoo et al.
2015), and the corrections published by Quek et al. (2014).
Due to their necessity for the development of tissue-
specific models, the accurate definition of GPR relation-
ships are of particular importance in multicellular, mam-
malian reconstructions. GPRs allow the development of
models implementing constraints based upon experimen-
tally measured expression data (Lee et al. 2012; Pornput-
tapong et al. 2015; Uhle´n et al. 2015). It follows that the
accuracy of such models is directly dependent upon the
accuracy of the gene associations in the original recon-
struction. Gene association updates from a previous Recon
2 iteration (Recon 2.04, http://vmh.uni.lu) and further
manual corrections and updates have also been incorpo-
rated into the present version. Previous human recon-
structions used a variety of identifiers, mostly from NCBI,
to denote genes. In Recon 2.2 genes are now represented
using HGNC identifiers, the worldwide authority for
assignment of standardised nomenclature to human genes.
A major goal for Recon 2.2 was to improve the simu-
lation of energy metabolism. Towards this end, both
mitochondrial and peroxisomal fatty acid oxidation were
redefined and expanded by replacing previously lumped
reactions with constituent two carbon cycle reactions (e.g.
an n carbon fatty acid to an n-2 carbon fatty acid), for both
saturated and unsaturated fatty acids. Genes associated
with fatty acid oxidation have also have been expanded.
Significant improvements also were made by redefining
the representation of oxidative phosphorylation. Specifi-
cally, this involved the definition of a new compartment,
the mitochondrial intramembrane space, and the use of this
compartment to define an electrochemical proton gradient.
Introducing this specific pool of transmembrane protons
enforces the coupling between the reactions of the electron
transport chain with that of ATP synthase, and thus the
coupling of mitochondrial NADH oxidation and O2
reduction with ATP production (Martı´nez et al. 2014).
While there may be inevitable simplifications of the rep-
resentation of the mitochondrial intramembrane space in
the model, its addition greatly improves the results of ATP
flux predictions and will act as an incentive for further
subsequent curation. The updated reactions are given in
Supplementary Information: Table S1.
Recon 2 included reactions with incomplete mass and
charge balancing (Table 1). Despite well over 90 % of
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reactions being correctly balanced, the presence of even a
small number of incorrectly balanced reactions is sufficient
for leaks (the erroneous or ‘alchemical’ creation of mass)
to occur, which can lead to unreliable flux predictions. To
address this in Recon 2.2, an automated reaction balancing
method, originally introduced in the SuBliMinaL Toolbox
software suite (Swainston et al. 2011), was extended and
applied. The original algorithm employed linear program-
ming to check and correct reaction stoichiometry based
upon element and charge counts of the reaction partici-
pants. It was also able to add ‘missing’ protons and water
molecules, which are commonly absent from reaction
definitions. This algorithm has been extended here to bal-
ance reactions involving non-specific metabolites, that is,
those containing generic R-groups (‘Markush structures’),
or those containing repeating units [e.g. (CH2)n]. The use
of R-groups is especially prevalent in Recon 2 in defining
lipid metabolism, where in the interests of simplicity,
multiple reactions involving fatty acids of differing chain
lengths were condensed into a single reaction. The
R-groups that remain are those representing conserved
moieties such as acyl-carrier protein (ACP), which cannot
be represented as a defined chemical formula but whose
presence do not affect the mass and charge balancing of
reactions.
Reversible reactions that thermodynamics suggest
should be unidirectional under typical physiological con-
ditions can also impact the accuracy of model predictions.
Many of these have been discovered through multiple
rounds of manual curation, driven by the requirement to
predict realistic ATP yields. This iterative process involved
performing a flux-balance analysis (FBA) test, inspecting
the resulting flux pattern for anomalous reactions, and
correcting their directionality based on literature searches
and definitions in pathway databases.
Previous work has highlighted the advantages of aug-
menting metabolic reconstructions with unambiguous,
publicly available identifiers mapping elements to entries
in persistent, external data resources (Herrga˚rd et al. 2008).
Due to its breadth and accuracy, ChEBI (Hastings et al.
2016) has become a de facto standard for the annotation of
metabolic species in systems biology models. Recon 2.2
has been further curated to expand the number of
metabolites that are annotated to ChEBI entries. Addi-
tionally, metabolites that are not currently in the ChEBI
database have been submitted to the ChEBI curators with
the intention of expanding the database, and incorporating
these new ChEBI identifiers into a subsequent iteration . In
the interim, Recon 2.2 metabolites have been annotated
with InChI string representations of molecular structure.
A comparison of maximum ATP yields per unit of car-
bon source was calculated for a number of existing models,
under both aerobic and anaerobic conditions. The results
show that, in contrast to previous versions, Recon 2.2 is able
to correctly predict maximum ATP fluxes. The results are
given in Table 2 and Supplementary Information: Table S2.
To summarise, Recon 2.2 compiles updates from the
various different updates to Recon 2.0 that have been
published. In addition, hundreds of novel manual updates
have been included, and semi-automatic checks have been
conducted to create a new consensus human metabolic
reconstruction and associated model. Importantly, Recon
2.2 has eliminated all mass leaks from improperly balanced
reactions that resulted in previous models being able to
simulate growth without a carbon source. ATP synthesis is
also now coupled to carbon availability. Simulation of
growth and energy metabolism using Recon 2.2 gives
biologically realistic results.
Annotations in Recon 2.2 have been improved by
increasing the use of ChEBI identifiers for metabolites, and
Table 1 Reconstruction scope
Recon 2.2 Quek Recon 2.1 Recon 2.04 Recon 2 Recon 1
Metabolites 5324 4962 5056 5063 5063 2766
Reactions 7785 7327 8089 7440 7440 3742
Balanced 7780 6761 7916 6948 6948 431
Unbalanced 0 211 51 94 94
Unknown 5a 355 122 398 398 3311
Genes 1675b 2167 2193 2140 2191
Recon 2.2 has increased the number of metabolites and reactions catalogued in the reconstruction relative
to Recon 2, and the reactions have now been verified and corrected for mass balance. Note that boundary
metabolites are excluded from this table (boundary metabolites being those outside of the system). The
values for metabolites and reactions therefore correspond to the size of the stoichiometry matrix
a The 5 unbalanced reactions remaining in Recon 2.2 are those relating to the biomass objective function
b There appears to be fewer genes in Recon 2.2 than in previous reconstructions, due to the movement to
representing genes by HGNC identifiers, which group alternative transcripts or splice variants into a single
entity
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standardising gene annotations to HGNC. During this
process numerous misannotations were removed and new
annotations incorporated.
The development of Recon 2.2 followed a semi-auto-
mated approach. The introduction of this approach pro-
vides full traceability of the updates implemented, and will
facilitate and accelerate the process of developing subse-
quent updates (to both the human and any other constraint-
based metabolic model). Regarding simplicity, updates are
supplied in simple text files that are parsed and interpreted
by custom software. By providing the facility to update
models in such an automated manner, the potential user
base for the model building process expands beyond those
that have an intimate understanding of software, and of
formats such as SBML and the COBRA Toolbox. The
benefits in terms of promoting reproducible science are
also clear: all changes made to a given model to produce a
new version are catalogued in text files, which essentially
act as a diff1 between versions. Finally, once the underlying
software to interpret the text files has been written, the
process of further developing future iterations of the model
rests solely in writing updated text files. This approach
allows the model developer to focus on the content of the
updates, rather than the technical means of implementing
them.
Table 2 Comparison of
maximum ATP yields under
different carbon sources and
oxygenation
Carbon source ATP yield
Theoreticala Recon 2.2 Quek Recon 2.04 Recon 2 Recon 1
Aerobic
glc, aerobic 31 32 ? ? ? ?
fru, aerobic 31 32 ? ? ? ?
C4:0, aerobic 21.5 22 ? ? ? ?
C6:0, aerobic 35.25 36 b b b b
C8:0, aerobic 49 50 ? ? ? ?
C10:0, aerobic 62.75 64 ? ? ? b
C12:0, aerobic 76.5 82.5 ? ? ? b
C14:0, aerobic 90.25 92 ? ? ? ?
C16:0, aerobic 104 106.75 ? ? ? ?
C18:0, aerobic 117.75 120.0 ? ? ? ?
C20:0, aerobic 131.5 134 ? ? ? ?
C22:0, aerobic 145.25 147.25 ? ? ? b
C24:0, aerobic 159 160.5 ? ? ? ?
C26:0, aerobic 172.75 170.75 ? ? ? ?
Anaerobic
glc, anaerobic 2 2 ? ? ? ?
fru, anaerobic 2 2 ? ? ? ?
C4:0, anaerobic 0 0 ? ? ? ?
C6:0, anaerobic 0 0 b b b b
C8:0, anaerobic 0 0 ? ? ? ?
C10:0, anaerobic 0 0 ? ? ? b
C12:0, anaerobic 0 0 ? ? ? b
C14:0, anaerobic 0 0 ? ? ? ?
C16:0, anaerobic 0 0 ? ? ? ?
C18:0, anaerobic 0 0 ? ? ? ?
C20:0, anaerobic 0 0 ? ? ? ?
C22:0, anaerobic 0 0 ? ? ? b
C24:0, anaerobic 0 0 ? ? ? ?
C26:0, anaerobic 0 0 ? ? ? ?
Glc, glucose; fru, fructose; Cn:0, a saturated fatty acid of length n
a Theoretical yields are calculated according to Salway (2003)
b Carbon source was not present in the model
1 From Wikipedia: In computing, the diff utility is a data comparison
tool that calculates and displays the differences between two files.
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